Evidence mapPaperPMID 42483191Full record

ReviewFrontiers in immunology2026

The role and therapeutic prospects of intercellular communication and RNA m

Huicong Yan, Yuhang Wang, Cunyang Guo, Yifei Du, Fangqi Tian, Ping Xu

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huicong YanSchool of Public Health, Shandong Second Medical University, Weifang, Shandong, China.
Yuhang WangSchool of Public Health, Shandong Second Medical University, Weifang, Shandong, China.
Cunyang GuoLaboratory of Radiation-induced Diseases and Molecule-targeted Drugs, School of Food and Biomedicine, Zaozhuang University, Zaozhuang, Shandong, China.
Yifei DuLaboratory of Radiation-induced Diseases and Molecule-targeted Drugs, School of Food and Biomedicine, Zaozhuang University, Zaozhuang, Shandong, China.
Fangqi TianLaboratory of Radiation-induced Diseases and Molecule-targeted Drugs, School of Food and Biomedicine, Zaozhuang University, Zaozhuang, Shandong, China.
Ping XuLaboratory of Radiation-induced Diseases and Molecule-targeted Drugs, School of Food and Biomedicine, Zaozhuang University, Zaozhuang, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation-induced liver injury (RILI) is a common and severe complication of radiotherapy for abdominal and thoracic malignancies. Ionizing radiation triggers widespread alterations of the N

Indexed as

AdenosineCell CommunicationLiverRadiation InjuriesRNAAnimalsEpitranscriptomeHumansLiver DiseasesRNA MethylationSignal TransductionAdenosineN-methyladenosineRNAexosomehepatic fibrosisinflammationintercellular communicationm6A modificationradiation-induced liver disease

Identifiers

PMID42483191
PMCPMC13384858

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.